Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and ...

Ginkgo Bioworks (DNA) announced that the Environmental Molecular Sciences Laboratory, or EMSL, at Pacific Northwest National Laboratory, or PNNL, a leading U.S. Department of Energy Office of Science ...

Ginkgo Bioworks Holdings has risen more than 5% past a 10.89 entry in a first-stage flat base, meaning it's now out of a ...

On that note, on August 29 Ginkgo Bioworks (DNA -3.86%) announced that it is joining forces with Alphabet, Google's parent company, in a five-year strategic partnership to develop and use new ...

Ginkgo vs. Placebo It is not clear how many people in the United States take ginkgo biloba, but sales of the supplement exceeded $249 million in 2006.

Ginkgo Bioworks stock plunged as much as 24% on Wednesday after a short-seller report from Scorpion Capital alleged that the synthetic biology company is a "Frankenstein mash-up of the worst frauds." ...

Ginkgo’s story matters because it has become the face of synthetic biology to many investors as it prepares to begin trading as a public stock in September following a merger with a special ...

Boston-based Ginkgo and Soaring Eagle announced in May that they had inked a deal that valued Ginkgo at $15 billion and would produce up to $2.5 billion in proceeds. Soaring Eagle is the seventh ...